Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Setmelanotide

EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway

Rhythm · Phase 3 · Completed · Enrollment 296

NCT05093634

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
POMC or PCSK1 variantn/rn/rn/rn/r
LEPR variantn/rn/rn/rn/r
NCOA1 (SRC1) variantn/rn/rn/rn/r
SH2B1 variantn/rn/rn/rn/r

Not shown

  • POMC or PCSK1 variant: endpoint not reported
  • LEPR variant: endpoint not reported
  • NCOA1 (SRC1) variant: endpoint not reported
  • SH2B1 variant: endpoint not reported